The anticancer natural product ophiobolin A induces cytotoxicity by covalent modification of phosphatidylethanolamine
Phenotypic screens allow the identification of small molecules with promising anticancer activity, but the difficulty in characterizing the mechanism of action of these compounds in human cells often undermines their value as drug leads. Here, we used a loss-of-function genetic screen in human haplo...
Main Authors: | Christopher Chidley, Sunia A Trauger, Kıvanç Birsoy, Erin K O'Shea |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2016-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/14601 |
Similar Items
-
Protein covalent modification of biologically active quinones
by: Sladić Dušan M., et al.
Published: (2004-01-01) -
Protein covalent modification by biologically active quinones
by: MIROSLAV J. GASIC, et al.
Published: (2004-11-01) -
Covalent Chemical Tools for Profiling Post-Translational Modifications
by: Benjamin Emenike, et al.
Published: (2022-07-01) -
Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine
by: Shrika G. Harjivan, et al.
Published: (2021-03-01) -
Polygodial and Ophiobolin A Analogues for Covalent Crosslinking of Anticancer Targets
by: Vladimir Maslivetc, et al.
Published: (2021-10-01)